Bone Biologics (BBLG) Non Operating Income (2014 - 2025)
Bone Biologics (BBLG) reported Non Operating Income of $88334.0 for Q4 2025, up 165.88% year-over-year from $33223.0 in Q4 2024, and up 81.99% quarter-over-quarter from $48537.0 in Q3 2025.
Bone Biologics (BBLG) Non Operating Income (2014 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 9 years of Non Operating Income data on file, last reported at $88334.0 in Q4 2025.
- Non Operating Income for Q4 2025 came in at $88334.0, up 165.88% year-over-year; the trailing twelve-month figure through Dec 2025 was $165821.0 (up 55.35% YoY), and the FY2025 annual result was $983054.0, up 820.97% from the prior year.
- Non Operating Income rose to $88334.0 in Q4 2025 per BBLG's latest filing, from $48537.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $1.3 million in Q2 2023 and troughed at -$562362.0 in Q1 2023.
- A 3-year average of $62677.8 and a median of $29577.5 in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income sank 97.96% in 2024, then soared 384.45% in 2025.
- A 3-year view of Non Operating Income shows it stood at -$389877.0 in 2023, then soared by 108.52% to $33223.0 in 2024, then soared by 165.88% to $88334.0 in 2025.
- Business Quant data shows BBLG's Non Operating Income at $88334.0 in Q4 2025, $48537.0 in Q3 2025, and $7556.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 9.35 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | 88,334.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 88,334.00 |
| Sep 30, 2025 | 48,537.00 |
| Jun 30, 2025 | 7,556.00 |
| Mar 31, 2025 | 21,394.00 |
| Dec 31, 2024 | 33,223.00 |
| Sep 30, 2024 | 10,019.00 |
| Jun 30, 2024 | 25,932.00 |
| Mar 31, 2024 | 37,566.00 |
| Dec 31, 2023 | -389,877.00 |
| Sep 30, 2023 | 161,181.00 |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | -562,362.00 |
| Dec 31, 2019 | -253,554.00 |
| Sep 30, 2019 | -260,070.00 |
| Dec 31, 2018 | -231,760.00 |
| Sep 30, 2018 | -646,528.00 |
| Dec 31, 2017 | -1.46 Mn |
| Sep 30, 2017 | -1.24 Mn |
| Jun 30, 2017 | -957,062.00 |
| Mar 31, 2017 | -762,352.00 |